Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Daily CF101 Administered Orally, When Added to Weekly Methotrexate, in Patients With Active Rheumatoid Arthritis
Latest Information Update: 19 Sep 2023
Price :
$35 *
At a glance
- Drugs Piclidenoson (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Can-Fite BioPharma
- 01 May 2009 Primary endpoint 'American College of Rheumatology 20% response criteria' has not been met.
- 12 Aug 2007 Status changed from in progress to completed.
- 12 Aug 2007 Interim results have been reported.